Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients

Altered glycosylation in epithelial cancers may play an important role in tumour progression, as it may affect tumour cell migration and antigen presentation by antigen presenting cells. We specifically characterise the glycosylation patterns of two tumour antigens that are highly expressed in cancer tissue and often detected in their secreted form in serum: the epithelial mucin MUC1 and carcinoembryonic antigen (CEA, also called CEACAM5). We analysed 48 colorectal cancer patients, comparing normal colon and tumour epithelium within each patient. Lectin binding was studied by a standardised CEA/MUC1 capture ELISA, using several plant lectins, and the human C‐type lectins MGL and DC‐SIGN, and Galectin‐3. Peanut agglutinin (PNA) bound to MUC1 from tumour tissue in particular, suggests increased expression of the Thomsen‐Friedenreich antigen (TF‐antigen) (Core 1, Galβ1‐3GalNAc‐Ser/Thr). Only small amounts of Tn‐antigen (GalNAcα‐Ser/Thr) expression was observed, but the human C‐type lectin MGL showed increased binding to tumour‐associated MUC1. Furthermore, sialylation was greatly enhanced. In sharp contrast, tumour‐associated CEA (CEACAM5) contained high levels of the blood‐group related carbohydrates, Lewis X and Lewis Y. This correlated strongly with the interaction of the human C‐type lectin DC‐SIGN to tumour‐associated CEA, suggesting that CEA can be recognized and taken up by antigen presenting cells. In addition, increased mannose expression was observed and branched N‐glycans were prominent, and this correlated well with human Galectin‐3 binding. These data demonstrate that individual tumour antigens contain distinct glycan structures associated with cancer and, since glycans affect cellular interactions with its microenvironment, this may have consequences for progression of the disease.

[1]  J. Rhodes,et al.  Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis , 2010, Molecular Cancer.

[2]  S. Kellokumpu,et al.  Golgi pH, its regulation and roles in human disease , 2012, Annals of medicine.

[3]  R. Lotan,et al.  The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). , 1975, The Journal of biological chemistry.

[4]  T. Geijtenbeek,et al.  Cutting Edge: Carbohydrate Profiling Identifies New Pathogens That Interact with Dendritic Cell-Specific ICAM-3-Grabbing Nonintegrin on Dendritic Cells , 2003, The Journal of Immunology.

[5]  R. Cummings,et al.  Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. , 1982, The Journal of biological chemistry.

[6]  G. Meijer,et al.  The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma , 2007, Cancer Immunology, Immunotherapy.

[7]  Y. Kim,et al.  Carbohydrate antigens on cancer-associated mucin-like molecules. , 1991, Seminars in cancer biology.

[8]  G. Meijer,et al.  Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. , 2005, Cancer research.

[9]  S. Hakomori,et al.  Carbohydrate determinants associated with carcinoembryonic antigen (CEA). , 1985, Journal of Immunology.

[10]  J. Taylor‐Papadimitriou,et al.  Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells. , 2003, The Biochemical journal.

[11]  R. Alon,et al.  Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions , 2001, Glycoconjugate Journal.

[12]  Masaki Kitajima,et al.  Expression of Sialyl Lewisa as a new prognostic factor for patients with advanced colorectal carcinoma , 1995 .

[13]  M. Kuroki,et al.  Structural studies of the carbohydrate moieties of carcinoembryonic antigens. , 1987, Cancer research.

[14]  S. Narasimhan.  Control of glycoprotein synthesis. UDP-GlcNAc:glycopeptide beta 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. , 1982, The Journal of biological chemistry.

[15]  J. Jessurun,et al.  The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 β-1,6-N-acetylglusaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas , 2009, BMC Cancer.

[16]  P. Stanley,et al.  Tumor and Stem Cell Biology Cancer Research The Bisecting GlcNAc on N-Glycans Inhibits Growth Factor Signaling and Retards Mammary Tumor Progression , 2010 .

[17]  J. Dennis,et al.  Suppression of tumor growth and metastasis in Mgat5-deficient mice , 2000, Nature Medicine.

[18]  Boris Tefsen,et al.  Regulation of expression and secretion of galectin-3 in human monocyte-derived dendritic cells. , 2009, Molecular immunology.

[19]  Ken S Lau,et al.  N-Glycans in cancer progression. , 2008, Glycobiology.

[20]  T. Okada,et al.  Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  David F. Smith,et al.  Immobilized Lotus tetragonolobus agglutinin binds oligosaccharides containing the Lex determinant , 2004, Glycoconjugate Journal.

[22]  S. Hammarström.  The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. , 1999, Seminars in cancer biology.

[23]  Xiao-lian Zhang,et al.  Knockdown of Mgat5 Inhibits Breast Cancer Cell Growth with Activation of CD4+ T Cells and Macrophages1 , 2008, The Journal of Immunology.

[24]  D. Santini,et al.  Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. , 2007, Glycobiology.

[25]  S. Brooks.  The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression. , 2000, Histology and histopathology.

[26]  J. Dennis,et al.  Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V , 1995, The Journal of cell biology.

[27]  Y. van Kooyk,et al.  Sweet preferences of MGL: carbohydrate specificity and function. , 2008, Trends in immunology.

[28]  R. Cummings,et al.  Specificity of DC‐SIGN for mannose‐ and fucose‐containing glycans , 2006, FEBS letters.

[29]  G. Fechner,et al.  Difference in the ability of blood group-specific lectins and monoclonal antibodies to recognize the ABH antigens in human tissues , 1990, The Histochemical Journal.

[30]  Ola Blixt,et al.  Carbohydrate profiling reveals a distinctive role for the C-type lectin MGL in the recognition of helminth parasites and tumor antigens by dendritic cells. , 2005, International immunology.

[31]  H. Sakahara,et al.  Distribution of Tn antigen recognized by an anti-Tn monoclonal antibody (MLS128) in normal and malignant tissues of the digestive tract , 2005, Journal of Cancer Research and Clinical Oncology.

[32]  Kim Ys,et al.  Carbohydrate antigens on cancer-associated mucin-like molecules. , 1991 .

[33]  S. Baldus,et al.  Characterization of the binding specificity ofAnguilla anguilla agglutinin (AAA) in comparison toUlex europaeus agglutinin I (UEA-I) , 1996, Glycoconjugate Journal.

[34]  M. Kitajima,et al.  Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma. , 1995, Cancer.

[35]  I. Goldstein,et al.  Carbohydrate-binding specificity of the daffodil (Narcissus pseudonarcissus) and amaryllis (Hippeastrum hybr.) bulb lectins. , 1990, Archives of biochemistry and biophysics.

[36]  M. Kurimoto,et al.  Involvement of galectin-3 expression in colorectal cancer progression and metastasis. , 1999, International journal of oncology.

[37]  K. Lloyd,et al.  Expression of Lewisa, Lewisb, Lewisx, Lewisy, siayl-Lewisa, and sialyl-Lewisx blood group antigens in human gastric carcinoma and in normal gastric tissue. , 1989, Cancer research.

[38]  C. Cordon-Cardo,et al.  Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. , 1986, Cancer research.

[39]  Y. Kim,et al.  Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. , 1989, Cancer research.

[40]  I. Finnie,et al.  Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. , 1995, The Journal of clinical investigation.

[41]  B. Yin,et al.  Serological and immunochemical analysis of Lewis Y (Ley) blood group antigen expression in epithelial ovarian cancer , 1996, International journal of cancer.

[42]  David F. Smith,et al.  Galectin-1, -2, and -3 Exhibit Differential Recognition of Sialylated Glycans and Blood Group Antigens* , 2008, Journal of Biological Chemistry.

[43]  Y. Kooyk,et al.  Protein-glycan interactions in the control of innate and adaptive immune responses , 2008, Nature Immunology.

[44]  Denny G. A. Johansson,et al.  Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin , 2006, Nature Structural &Molecular Biology.

[45]  E. Campo,et al.  Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. , 1997, Gastroenterology.

[46]  J. Hirabayashi,et al.  Galectin-3 Interaction with Thomsen-Friedenreich Disaccharide on Cancer-associated MUC1 Causes Increased Cancer Cell Endothelial Adhesion* , 2007, Journal of Biological Chemistry.

[47]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.

[48]  N. Peat,et al.  Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. , 1990, The Journal of biological chemistry.

[49]  L. Sachs,et al.  Specific inhibition by N-acetyl-D-galactosamine of the interaction between soybean agglutinin and animal cell surfaces. , 1970, Biochimica et biophysica acta.

[50]  I. Ellis,et al.  High expression of Lewisy/b antigens is associated with decreased survival in lymph node negative breast carcinomas , 2005, Breast Cancer Research.

[51]  M. Litjens,et al.  Tumour‐associated glycan modifications of antigen enhance MGL2 dependent uptake and MHC class I restricted CD8 T cell responses , 2011, International journal of cancer.